America Great Health (AAGH)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 5, 2026, 9:30 AM EST
America Great Health Revenue
In the fiscal year ending June 30, 2025, America Great Health had annual revenue of $391.74K with 32.94% growth. America Great Health had revenue of $104.53K in the quarter ending June 30, 2025, with 9.28% growth.
Revenue
391.74K
Revenue Growth
+32.94%
P/S Ratio
0.05
Revenue / Employee
78.35K
Employees
5
Market Cap
21.15K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 391.74K | 97.07K | 32.94% |
| Jun 30, 2024 | 294.67K | 90.36K | 44.23% |
| Jun 30, 2023 | 204.31K | 99.66K | 95.23% |
| Jun 30, 2022 | 104.65K | -91.02K | -46.52% |
| Jun 30, 2021 | 195.67K | 190.20K | 3,474.55% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Carisma Therapeutics | 52.63M |
| ObsEva | 19.64M |
| Scorpius Holdings | 1.72M |
| Syros Pharmaceuticals | 386.00K |
| Entia Biosciences | 265.47K |
| Health Sciences Group | 69.31K |
| NanoLogix | 1.27K |